-
Cancer Comes OutMembers of LGBT community are at greater risk for some types of cancer. And those with cancer face challenges in getting the care and support they need.
by Cameron Walker
-
Healthy Habits
Fruitful ChoicesEating fruits in teen years associated with lower breast cancer risk later.
by Lindsey Konkel
-
Forward Look
Getting to the Root of Brain CancerQ&A with neurosurgeon Peter Dirks on stem cells and brain cancer.
by Chris Palmer
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Forward Look
Breast Cancer Survivors and Vaginal EstrogenExpert opinion affirms need to weigh risks and benefits.
by Kate Yandell
-
Forward Look
A Report Card on Active SurveillanceMany men with untreated prostate cancer are not getting proper follow-up.
by Heather Stringer
-
Forward Look
Radiation Appointments Are Numerous, And NecessaryNew study shows impact of missed treatments.
by Marilyn Fenichel
-
Treatment Is WaitingFor patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
-
The Riddle of Bacteria and CancerBacteria can be friend or foe—or both. Researchers are looking at bacteria to boost the effectiveness of cancer treatments, even if they don't fully understand how the tiny organisms work.
by Stephen Ornes
-
Editor's Letter
Cancer and Watchful WaitingWatching and waiting for cancer to progress can be an alternative to active treatment.
by Kevin McLaughlin
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
